| For: | Zhao JJ, Han CY, Xu GX, Zhou M, Jin ZM. Effect of lurasidone plus sulpiride on treatment efficacy, psychiatric manifestations, and quality of life among patients with schizophrenia. World J Psychiatry 2025; 15(10): 105932 [PMID: 41112605 DOI: 10.5498/wjp.v15.i10.105932] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v15/i10/105932.htm |
| Number | Citing Articles |
| 1 |
I. Yu. Dorozhenok, S. Jovic, D. A. Koriakin. Sulpiride (Eglonil) in the treatment of somatoform and anxiety disorders. A review of the literature. Neurology, Neuropsychiatry, Psychosomatics 2026; 18(2) doi: 10.14412/2074-2711-2026-2-85-92
|
| 2 |
Eleonora Corridori, Alessia Marchesin, Camilla Amato, Veronica Begni, Sara Salviati, Carla Gambarana, Marco Andrea Riva, Simona Scheggi. Dose-dependent modulation of social and motivational behavior by lurasidone in a rat model of social defeat. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2026; 147 doi: 10.1016/j.pnpbp.2026.111756
|